Clinical trial
Futility Study of Deferoxamine in Intracerebral Hemorrhage
NCT01662895 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Futility Study of Deferoxamine in Intracerebral Hemorrhage
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- March 18, 2013
- Completion date
- May 10, 2018
- Enrollment
- 42 (actual)
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.
intracerebral hemorrhage